LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Lexaria Bioscience Corp.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026
$2.60−0.26 (-9.09%)
Close on Oct 19, 2026
- Market cap
- $64.50M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Lexaria Bioscience has not reported a dividend
No dividend per share appears in Lexaria Bioscience's annual filings since fiscal 2009.